434 related articles for article (PubMed ID: 18160575)
41. Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.
Asakura H; Hifumi S; Jokaji H; Saito M; Kumabashiri I; Uotani C; Morishita E; Yamazaki M; Shibata K; Mizuhashi K
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):469-73. PubMed ID: 1420823
[TBL] [Abstract][Full Text] [Related]
42. The John Charnley Award. Thrombogenesis during total hip arthroplasty.
Sharrock NE; Go G; Harpel PC; Ranawat CS; Sculco TP; Salvati EA
Clin Orthop Relat Res; 1995 Oct; (319):16-27. PubMed ID: 7554626
[TBL] [Abstract][Full Text] [Related]
43. D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis.
Bozic M; Blinc A; Stegnar M
Thromb Res; 2002 Nov; 108(2-3):107-14. PubMed ID: 12590945
[TBL] [Abstract][Full Text] [Related]
44. D-dimer and thrombin-antithrombin III complex levels uncorrelated with phlebographic findings in 11 total knee replacement patients.
De Prost D; Ollivier V; Vie P; Benacerraf R; Duparc J; Khoury A
Ann Biol Clin (Paris); 1990; 48(4):235-8. PubMed ID: 2193559
[TBL] [Abstract][Full Text] [Related]
45. Preoperative plasma levels of prothrombin fragment 1 + 2 correlate with the risk of venous thrombosis after elective hip replacement.
Corradi A; Lazzaro F; Cofrancesco E; Cortellaro M; Ravasi F; Bertocchi F
Acta Orthop Belg; 1999 Mar; 65(1):39-43. PubMed ID: 10217000
[TBL] [Abstract][Full Text] [Related]
46. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
47. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction?
Ben-Ari Z; Osman E; Hutton RA; Burroughs AK
Am J Gastroenterol; 1999 Oct; 94(10):2977-82. PubMed ID: 10520855
[TBL] [Abstract][Full Text] [Related]
48. Effect of homocysteine reduction by B-vitamin supplementation on markers of clotting activation.
Klerk M; Verhoef P; Verbruggen B; Schouten EG; Blom HJ; Bos GM; den Heijer M
Thromb Haemost; 2002 Aug; 88(2):230-5. PubMed ID: 12195694
[TBL] [Abstract][Full Text] [Related]
49. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.
Kamikura Y; Wada H; Nobori T; Matsumoto T; Shiku H; Ishikura K; Yamada N; Nakano T; Kazahaya Y; Sawai T; Matsuda M
Thromb Res; 2005; 115(1-2):53-7. PubMed ID: 15567453
[TBL] [Abstract][Full Text] [Related]
50. Fibrin D-dimer, markers of coagulation activation and the risk of major ischaemic heart disease in the caerphilly study.
Lowe GD; Rumley A; Sweetnam PM; Yarnell JW; Rumley J
Thromb Haemost; 2001 Sep; 86(3):822-7. PubMed ID: 11583314
[TBL] [Abstract][Full Text] [Related]
51. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
52. Increased ratio of soluble fibrin formation/thrombin generation in patients with DIC.
Kushimoto S; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Seki Y; Hatada T; Imai H; Nobori T;
Clin Appl Thromb Hemost; 2012 Nov; 18(6):628-32. PubMed ID: 22751910
[TBL] [Abstract][Full Text] [Related]
53. Activation of coagulation and fibrinolytic systems in patients with CLI is not normalized after surgical revascularisation.
Pärsson H; Holmberg A; Siegbahn A; Bergqvist D
Eur J Vasc Endovasc Surg; 2004 Feb; 27(2):186-92. PubMed ID: 14718902
[TBL] [Abstract][Full Text] [Related]
54. Laboratory signs of activated coagulation are common in Henoch-Schönlein purpura.
Brendel-Müller K; Hahn A; Schneppenheim R; Santer R
Pediatr Nephrol; 2001 Dec; 16(12):1084-8. PubMed ID: 11793106
[TBL] [Abstract][Full Text] [Related]
55. Prothrombin fragment 1.2 in both treated and untreated hypertensive patients.
Donders SH; Lustermans FA; van Wersch JW
Neth J Med; 1993 Oct; 43(3-4):174-8. PubMed ID: 8302396
[TBL] [Abstract][Full Text] [Related]
56. Measurement of soluble fibrin monomer-fibrinogen complex in plasmas derived from patients with various underlying clinical situations.
Nakahara K; Kazahaya Y; Shintani Y; Yamazumi K; Eguchi Y; Koga S; Wada H; Matsuda M
Thromb Haemost; 2003 May; 89(5):832-6. PubMed ID: 12719780
[TBL] [Abstract][Full Text] [Related]
57. Levels of F(1+2) prothrombin fragments and thrombin - antithrombin III (TAT) complexes in patients with dermatitis herpetiformis.
Wankiewicz A; Iwan-Zietek I; Gwieździński Z; Kotschy M
Med Sci Monit; 2002 Aug; 8(8):BR324-7. PubMed ID: 12165736
[TBL] [Abstract][Full Text] [Related]
58. [Concentration of prothrombin fragments 1+2 (F1+2) and thrombin-antithrombin III complexes (TAT)in patients with primary non-small cell lung cancer, before and after resection].
Kostecka IA; Haponowicz B; Sienkiewicz P; Wierzbicka M
Przegl Lek; 2000; 57(9):451-4. PubMed ID: 11199863
[TBL] [Abstract][Full Text] [Related]
59. Hypercoagulability state in patients with chronic obstructive pulmonary disease. Chronic Obstructive Bronchitis and Haemostasis Group.
Alessandri C; Basili S; Violi F; Ferroni P; Gazzaniga PP; Cordova C
Thromb Haemost; 1994 Sep; 72(3):343-6. PubMed ID: 7855781
[TBL] [Abstract][Full Text] [Related]
60. [Evaluation of an enzyme-linked immunosorbent assay for the determination of prothrombin fragment F1.2 (Dade Prothrombin Fragment F1.2 ELISA: Baxter Diagnostics Inc., U.S.A.) using micro-titer plate].
Suzuki T; Amano K; Kuroso K; Fukutake K; Fujimaki M
Rinsho Byori; 1993 Feb; 41(2):215-9. PubMed ID: 8361024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
